Passero LF - Search Results

1

Histopathology, humoral and cellular immune response in the murine model of Leishmania (Viannia) shawi.

Passero LF, Marques C, Vale-Gato I, Corbett CE, Laurenti MD, Santos-Gomes G. Passero LF, et al. Parasitol Int. 2010 Jun;59(2):159-65. doi: 10.1016/j.parint.2009.12.010. Epub 2010 Jan 6. Parasitol Int. 2010. PMID: 20060062

2

The effect of phospholipase A2 from Crotalus durissus collilineatus on Leishmania (Leishmania) amazonensis infection.

Passero LF, Laurenti MD, Tomokane TY, Corbett CE, Toyama MH. Passero LF, et al. Parasitol Res. 2008 Apr;102(5):1025-33. doi: 10.1007/s00436-007-0871-6. Epub 2008 Jan 8. Parasitol Res. 2008. PMID: 18180953

3

Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi.

Passero LF, Sacomori JV, Tomokane TY, Corbett CE, da Silveira FT, Laurenti MD. Passero LF, et al. Parasitol Res. 2009 Nov;105(6):1741-7. doi: 10.1007/s00436-009-1614-7. Epub 2009 Sep 16. Parasitol Res. 2009. PMID: 19756748

4

Exacerbation of Leishmania (Viannia) shawi infection in BALB/c mice after immunization with soluble antigen from amastigote forms.

Passero LF, Da Costa Bordon ML, De Carvalho AK, Martins LM, Corbett CE, Laurenti MD. Passero LF, et al. APMIS. 2010 Dec;118(12):973-81. doi: 10.1111/j.1600-0463.2010.02679.x. Epub 2010 Sep 14. APMIS. 2010. PMID: 21091779

5

Analysis of the protective potential of antigens released by Leishmania (Viannia) shawi promastigotes.

Passero LF, Marques C, Vale-Gato I, Corbett CE, Laurenti MD, Santos-Gomes G. Passero LF, et al. Arch Dermatol Res. 2012 Jan;304(1):47-55. doi: 10.1007/s00403-011-1171-7. Epub 2011 Sep 1. Arch Dermatol Res. 2012. PMID: 21882046

6

Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.

Passero LF, Carvalho AK, Bordon ML, Bonfim-Melo A, Toyama MH, Corbett CE, Laurenti MD. Passero LF, et al. Inflamm Res. 2012 Mar;61(3):255-63. doi: 10.1007/s00011-011-0407-5. Epub 2011 Dec 14. Inflamm Res. 2012. PMID: 22166919

7

Plants used in traditional medicine: extracts and secondary metabolites exhibiting antileishmanial activity.

Passero LF, Laurenti MD, Santos-Gomes G, Soares Campos BL, Sartorelli P, Lago JH. Passero LF, et al. Curr Clin Pharmacol. 2014;9(3):187-204. doi: 10.2174/1574884709999140606161413. Curr Clin Pharmacol. 2014. PMID: 23173968 Review.

8

Dynamic of the cellular immune response at the dermal site of Leishmania (L.) amazonensis and Leishmania (V.) braziliensis infection in Sapajus apella primate.

Laurenti MD, Passero LF, Tomokane TY, Francesquini Fde C, Rocha MC, Gomes CM, Corbett CE, Silveira FT. Laurenti MD, et al. Among authors: passero lf. Biomed Res Int. 2014;2014:134236. doi: 10.1155/2014/134236. Epub 2014 Aug 28. Biomed Res Int. 2014. PMID: 25309902 Free PMC article.

9

Conventional Versus Natural Alternative Treatments for Leishmaniasis: A Review.

Passero LFD, Cruz LA, Santos-Gomes G, Rodrigues E, Laurenti MD, Lago JHG. Passero LFD, et al. Curr Top Med Chem. 2018;18(15):1275-1286. doi: 10.2174/1568026618666181002114448. Curr Top Med Chem. 2018. PMID: 30277153 Review.

10

Activity of Fenticonazole, Tioconazole and Nystatin on New World Leishmania Species.

Yamamoto ES, Jesus JA, Bezerra-Souza A, Laurenti MD, Ribeiro SP, Passero LFD. Yamamoto ES, et al. Curr Top Med Chem. 2018;18(27):2338-2346. doi: 10.2174/1568026619666181220114627. Curr Top Med Chem. 2018. PMID: 30569856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters